The alternatives
He & She MD scores 76/100 (grade C, ranked #74) on The Verdict Score. Here are the GLP-1 providers we'd weigh against it, scored on the same six-factor rubric. Partners we work with carry a small, fixed edge in where they are listed; the scores themselves are not adjusted.
This shortlist uses nearby positions in our published ranking, with our featured partner shown first. It compares program terms and features; your clinician must assess treatment suitability.
Published by The GLP-1 Verdict
Check dates vary by provider.
The most honest middle of the market: nationwide access, both molecules at one flat, no-surprise price.
CoreAge Rx scores 94/100 to He & She MD's 76, and our He & She MD vs CoreAge Rx comparison sets the two out factor by factor.
Fitish offers compounded semaglutide ($219/28 days) and compounded tirzepatide ($339/28 days) including consultation and shipping.
Fitish matches He & She MD at 76/100; our full write-up on Fitish has the pricing conditions and the caveats in detail.
Oral as well as injectable routes for both molecules plus a real brand Ozempic pathway, bundled with hair, TRT and sexual health on one platform.
Care Bare Rx scores 75/100 to He & She MD's 76; the full Care Bare Rx review has the pricing conditions and the caveats in detail.
Clean three-rung tables one click in, behind a homepage whose three cards all quote six-month rungs and whose cheapest is a different drug.
Edessa matches He & She MD at 76/100; our full write-up on Edessa has the pricing conditions and the caveats in detail.
An online treatment platform advertising time-limited compounded offers and branded prescription routes; ongoing payment terms need confirmation.
NextMeds scores 75/100 to He & She MD's 76; our full write-up on NextMeds has the pricing conditions and the caveats in detail.
A Florida telehealth that names all four of its compounding pharmacies and now sells brand-name Ozempic and Zepbound alongside compounded injections, but leads with a half-price first month.
Tryozi matches He & She MD at 76/100; our Tryozi review in full has the pricing conditions and the caveats in detail.
Claya is a direct-to-consumer telehealth platform offering compounded semaglutide and tirzepatide in both injectable and oral-tablet forms — a wider format range than most competitors.
Claya scores 75/100 to He & She MD's 76; the full Claya review has the pricing conditions and the caveats in detail.
See the complete rankings, the alternatives to every provider, A to Z, or head to the comparison hub.
Pricing, states and verification reflect each provider's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Not medical advice; see our disclosure.